IOVA - Iovance Biotherapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$2.00
DETAILS
HIGH:
$2.00
LOW:
$2.00
MEDIAN:
$2.00
CONSENSUS:
$2.00
DOWNSIDE:
50.98%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 97.2% |
| EBIT Margin | -149.2% |
| EBITDA Margin | -135.5% |
| Operating Margin | -153.1% |
| Pretax Margin | -149.2% |
| Cont. Ops Margin | -148.4% |
| Net Margin | -148.4% |
| Bottom Line Margin | -148.4% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 3.20 |
| Quick Ratio | 2.83 |
| Solvency Ratio | -1.655 |
| Cash Ratio | 1.18 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-2.50
Peers avg: 32.1
|
| PEG Ratio | 0.17 |
| Forward PEG | 0.17 |
| Price/Book | 1.40 |
| Price/Sales | 3.70 |
| Price/FCF | -2.90 |
| Price/Op Cash Flow | -3.23 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0531 |
| Debt/Equity | 0.0693 |
| Debt/Capital | 0.0648 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.31 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.82 |
| Operating Cash Flow Ratio | -2.186 |
| Operating Cash Flow/Sales | -114.8% |
| Free Cash Flow/Operating Cash Flow | 111.2% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -87.82 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -74.80 |
| Operating Cash Flow Coverage | -6.24 |
| Capital Expenditure Coverage | -8.94 |
| Dividend + Capital Expenditure Coverage | -8.94 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.74 |
| EPS | -1.094 |
| Debt/Share | 0.1356 |
| Cash/Share | 0.83 |
| Book Value/Share | 1.95 |
| Tangible BV/Share | 1.17 |
| Equity/Share | 1.95 |
| Operating Cash Flow/Share | -0.846 |
| Capital Expenditure/Share | 0.095 |
| FCF/Share | -0.941 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.995 |
| Earnings Before Tax/EBIT | 0.974 |
| Price/Fair Value | 1.40 |
| Debt/Market Cap | 0.0041 |
| Effective Tax Rate | 0.5% |
| Enterprise Value Multiple | -2.41 |